Madrigal Pharmaceuticals, Inc.
(Borse Berlin : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-0.79%66.5322.0%$199.81m
ZGNXZogenix, Inc.
2.36%39.0016.8%$132.38m
SHPGShire PLC Sponsored ADR
-3.79%146.290.4%$126.77m
VRXValeant Pharmaceuticals International, Inc.
-3.32%12.3914.2%$105.77m
PRGOPerrigo Co. Plc
-0.02%88.576.5%$92.63m
AERIAerie Pharmaceuticals, Inc.
-0.23%64.458.6%$64.60m
CTLTCatalent Inc
1.42%42.142.7%$57.25m
MNKMallinckrodt Plc
-0.57%32.1817.7%$56.13m
PTLAPortola Pharmaceuticals, Inc.
-0.42%50.297.9%$50.60m
JAZZJazz Pharmaceuticals Plc
-0.03%140.462.2%$49.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.32%111.167.6%$49.04m
UTHRUnited Therapeutics Corporation
-1.37%120.1214.4%$46.13m
ENDPEndo International Plc
0.13%7.658.9%$39.34m
SUPNSupernus Pharmaceuticals, Inc.
0.49%41.256.4%$37.02m
MDCOMedicines Company
-0.09%34.5422.1%$35.20m

Company Profile

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.